Global Blood Therapeutics Lands $40,700,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1c4a913f-ab2d-462c-b179-385d9ec3a3fa&Preview=1 - Date
6/15/2012 - Company Name
Global Blood Therapeutics - Mailing Address
455 Mission Bay Blvd South San Francisco, CA 94158 - Company Description
Global Blood Therapeutics, Inc. is a product-focused company building a pipeline of innovative, oral medicines to revolutionize the treatment of chronic blood-based diseases and severe genetic disorders for which there are currently no cures available and only extremely limited therapeutic options. - Website
http://www.globalbloodtx.com - Transaction Type
Venture Equity - Transaction Amount
$40,700,000 - Transaction Round
Series A - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Third Rock Ventures - Venture Investor
Undisclosed
